Research of SU

The college has sufficient research funds and first-class research facilities. There are three national scientific research platforms, four Jiangsu key laboratories or research centers, two Suzhou key laboratories, and two University scientific research institutions. The pharmacy discipline has been listed as the Priority Academic Program Development of Jiangsu Higher Education Institutes (PAPD) and the key discipline of Jiangsu Province during the Thirteenth Five-Year Plan. The Essential Science Indicator (ESI) of Pharmacology and Toxicology discipline of the college ranked in the top 0.87‰ of the world. The pharmacy major has been selected as the national first-class professional construction site. Since 2014, an English program for pharmacy majors has been set up, and the Pharmacology course was recognized by the National Ministry of Education as the featured English teaching course for international students.

Research of RCSI

The pioneering research directed by RCSI experts covers a broad range of health science disciplines, with a particular focus on itssix research pillars. Work in these areas has led to a number of discoveries that are having a profound effect on the understanding and treatment of diseases and disorders. Continued success in research awards from national and international funding bodies has led to RCSI having the highest success rate of any Irish institution in winning funding from the EU Horizon 2020 programme. As an indicator of the scale of RCSI research activities, in 2021, RCSI was awarded €37.5m in external research funding from national and international funders. RCSI annual income for 2020/21 was €175m of which €14.1m (8%) was invested in research. Annual research expenditure for 2021 was €24m (8% of which was from industry sources).

RCSI is ranked in the top 250 in the Times Higher World University Ranking 2023 and number one in the world for SDG3 ‘Good Health and Well-being’ in the Times Higher Education University Impact Rankings 2023, reflecting the University’s singular focus on improving human health for the benefit of patients and communities across the globe through translational research.